Literature DB >> 23019947

[Clinical research on Sanmiao powder combined fibrinogenase for injection in treatment of acute deep venous thrombosis of lower limbs].

Tao Zhou1, Da-Qing Sun, Peng Wu.   

Abstract

OBJECTIVE: To observe the clinical effectiveness of Sanmiao Powder (SP) combined fibrinogenase for injection in treatment of acute deep venous thrombosis (ADVT) of lower limbs.
METHODS: Eighty patients with ADVT were randomly assigned to two groups according to the disease course (within 7 days or 7-28 days), 40 in each group. Every time phase was also divided into two groups, i. e., one group treated with fibrinogenase for injection alone (Group A and C) and another group treated with fibrinogenase for injection + SP administration (Group B and D) , 20 in each group. The clinical effectiveness was observed after 2-week treatment.
RESULTS: The fibrinogenase for injection + SP administration showed better effects in alleviating the swelling of limbs, relieving pain, and lowering fibrinogen. Better effects were obtained in the group with the disease course less than 7 days.
CONCLUSION: Better effect on ADVT was obtained by integrative medicine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019947

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Traditional Chinese and western medicine for the prevention of deep venous thrombosis after lower extremity orthopedic surgery: a meta-analysis of randomized controlled trials.

Authors:  Shibai Zhu; Yi Song; Xi Chen; Wenwei Qian
Journal:  J Orthop Surg Res       Date:  2018-04-10       Impact factor: 2.359

2.  Elucidation of Potential Targets of San-Miao-San in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Man Chu; Ting Gao; Xu Zhang; Wulin Kang; Yu Feng; Zhe Cai; Ping Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-18       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.